← SynDRA
LIXUMISTAT
SynDRA canonical compound SYN0040199 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | NDUFS1 | PRKAA2 |
|---|
| Mechanism of action | ampk activator |
|---|
| Indication | breast cancer |
|---|
| Disease area | oncology |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- HL-156A FREE BASE
- HL156A FREE BASE
- HL271
- IM-156 FREE BASE
- IM156 FREE BASE
- IM-156 free base
- HL-156A free base
- IM156 free base
- HL156A free base
- 4G3BUV6ZSK
- RefChem:147913
- UNII-4G3BUV6ZSK
- lixumistat [INN]
- Lixumistat [WHO-DD]
- EX-A4660
- s9604
- AKOS040759445
- HY-136093B
- DA-54275
- DA-64193
- TS-09818
- CS-0142260
- T8532
- orb1298855
- SCHEMBL15830992
- SCHEMBL23035230
- SCHEMBL29919462
- C13H16F3N5O
- GLXC-22884
- IM156?
- MFCD32856762
- G65520
- NGFUHJWVBKTNOE-UHFFFAOYSA-N
- HL156A
- IM-156
- Lixumistat acetate
- IM156 acetate (HL156A; HL271 acetate)
- T36420
- G17409
Look up LIXUMISTAT in the interactive SynDRA portal →